A Study of Camrelizumab in Combination With Pemetrexed and Carboplatin /Cisplatin in Subjects With Lung Adenocarcinoma After Radiofrequency Ablation
Latest Information Update: 01 Dec 2020
At a glance
- Drugs Camrelizumab (Primary) ; Carboplatin (Primary) ; Cisplatin (Primary) ; Pemetrexed (Primary)
- Indications Adenocarcinoma; Lung cancer; Non-small cell lung cancer
- Focus Therapeutic Use
- 01 Dec 2020 New trial record